Eva Poveda | |
|---|---|
 Poveda in 2024 | |
| Born | 22 July 1975 |
| Education | USC |
| Employer | Galician Healthcare Service |
Eva Poveda López (born 22 July 1975) is a Spanish scientist who is a researcher at the Galician Healthcare Service (SERGAS), and coordinates the Consolidated Research Group on Virology and Pathogenesis at the Galicia Sur Health Research Institute, and has been the Scientific Director of the IIS Galicia Sur since 18 July 2022. She is a virologist and is considered an expert in the study of Human Immunodeficiency Virus (HIV) infection and viral hepatitis, and since April 2020 has expanded her research to include SARS-CoV-2/COVID-19 infection. Poveda has been a member of the Galician Government's Advisory Council for Research, Development and Innovation since 2016.
Poveda is the author of 197 articles published in international scientific journals with an h-index of 40. She leads national and international projects, primarily in Europe, the United States, and West Africa. Her research focuses on the epidemiological, clinical, virological, and pathogenic aspects of these infections. She has conducted research stays at Case Western Reserve University in the Laboratory of Interesting Immunology, directed by Michael Lederman. Since 2008, she has been a recipient of funding for research projects, human resources, mobility, and networks (principal investigator of the AIDS Research Network-RIS, RD16). Poveda is a member of the Executive Committee of the Adult Cohort of the National HIV/AIDS Network (CoRIS) and is the scientific coordinator and principal investigator of the IIS Galicia Sur COVID19 Cohort created in April 2020 with funding obtained from the ISCIII COVID19 Fund and which is part of the ISCIII-COVID19 Registry.
Poveda is a member of expert panels for the development of clinical guidelines and national consensus documents for the treatment and clinical follow-up of people living with HIV, such as the GESIDA/National AIDS Plan Consensus Document regarding antiretroviral treatment in HIV-infected adults, the document on the clinical utility of antiretroviral resistance, and coordinator of the Antiretroviral Resistance Guide of the AIDS Research Network, among others. She participates in scientific and organizing committees of national congresses and scientific meetings (GeSIDA National Congress) and is an editor (Microorganisms, Frontiers in Immunology, Pathogens and Immunity) and reviewer for international scientific journals.
In October 2025, she was appointed a member of the R&D Advisory Council of the Xunta de Galicia., which met for the first time for its constitution on 16 April 2026.
